NASDAQ:DCPH

Deciphera Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

DCPH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-1.28 $-1.21 $-1.13
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $23.36M $23.57M $15.45M

Deciphera Pharmaceuticals, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

DCPH Earnings Date & History Chart

DCPH Earnings & Revenue Forecast

DCPH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-1.30 $-1.46 $-1.19
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-4.85 $-5.06 $-4.69
Dec 2022 10 $-4.00 $-5.14 $-2.90

DCPH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 0 $-1.32 $-1.32 $-1.16
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-4.86 $-4.86 $-4.53
Dec 2022 1 / 1 $-3.84 $-3.84 $-3.25

DCPH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 10 $24.18M $21.80M $29.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $96.39M $91.98M $103.50M
Dec 2022 10 $177.02M $112.46M $258.50M

DCPH Earnings Date & Revenue History

DCPH Earnings History

|
Show More
Show More

DCPH Revenue History

|
Show More
Show More

Deciphera Pharmaceuticals, Inc Next Earnings Date & Report

DCPH Next Earnings Date & Report Preview: Sep 2021 (FQ)

DCPH's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 10 analysts, the average EPS estimation for Deciphera Pharmaceuticals, Inc's next quarterly earnings is $-1.28, with a low EPS estimation of $-1.37, and a high estimation of $-1.20.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 1 downward. The EPS 1 month trend is $-1.27, the last 2 month trend is $-1.27, and the 3 month trend is $-1.16.

Based on 9 analysts, the average revenue estimation is $23.36M, with a low revenue estimation of $21.29M, and a high estimation of $25.70M.

Deciphera Pharmaceuticals, Inc Previous Earnings Dates & Reports

DCPH Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Deciphera Pharmaceuticals, Inc's previous earnings date was Aug 3, 2021 for its fiscal quarter ended Jun 30, 2021.

DCPH's earnings per share (EPS) was $-1.21, missing the consensus analysts forecast of $-1.16 by -4.73%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 14.15%, and lower than the same period a year before (Jun 2020) by 0.83%.

Revenues were $23.57M, better than the forecast of $23.57M by 0.00%, down by -6.29% from the previous quarter , and up by 232.48% from the same period last year.

The company reported a net income of $-70.43M.

Free cash flow for the quarter was $-52.40M , compared to $-68.32M last quarter and $-63.83M a year before.

DCPH ended the quarter with $30.46M in total debt, a decrease of -1.69% compared to the previous quarter, and an increase of 82.33% compared to the same quarter a year before.

DCPH Previous Earnings Date & Report Recap: Dec 2020 (FY)

Deciphera Pharmaceuticals, Inc's previous annual earnings date was Feb 9, 2021 for its fiscal year ended Dec 31, 2020.

DCPH's earnings per share (EPS) was $-4.79, beating the consensus analysts forecast of $-4.84 by -1.03% , and lower than the previous year's EPS (Dec 2019) by 8.86%.

Revenues were $42.09M, better than the forecast of $41.43M by 1.59%, and up by 68.35% from previous year's revenue.

The company reported a net income of $-266.49M.

Deciphera Pharmaceuticals, Inc reported a free cash flow of $-245.00M for its fiscal year, compared to $-154.23M a year ago.

The company ended the fiscal year with $31.22M in total debt, an increase of 76.88% compared to the previous year.